APA Resident-Fellow Members
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, Fifth Edition
Edited by Marc Galanter, M.D., Herbert D. Kleber, M.D., and Kathleen T. Brady, M.D., Ph.D.
- 980 Pages
- Editorial Reviews
- ISBN 978-1-58562-518-5
- Item #62518
No other text available today offers what The American Psychiatric Publishing Textbook of Substance Abuse Treatment can: completely updated treatment information on a broad range of substance use disorders that is consistent with the new DSM-5 classification and thus reflective of how psychiatry is practiced today. Designed for researchers and mental health professionals ranging from trainee to licensed practitioner, the book is also appropriate for a diverse array of rehabilitation settings, from inpatient to community-based treatment. Full coverage is provided on 12-step programs, as well, including the latest outcomes research.
Much of the material is new to this edition:
- A chapter has been added on science in the treatment of substance abuse, in which the authors discuss the history of scientific intervention in substance abuse and explore what happens to the brain when addicting drugs are consumed, review animal models and imaging techniques, and discuss current progress in the science of addiction.
- Chapters have been added on screening and brief intervention, reflecting the development of brief screening tools and research on the efficacy of interventions, and the role of recovery in chronic care disease management—specifically what the treatment models for alcohol dependence and for diabetes can effectively borrow from each other.
- A new chapter focuses on the treatment of alcohol intoxication and withdrawal—the first steps in treatment of alcohol use disorder.
- Two chapters on marijuana—one on the neurobiology and one addressing treatment have been added. Given the accelerating trend toward decriminalization and legalization of this substance, clinicians will find this information of increasing importance.
- The section on substance use issues among gay men and lesbians has been expanded to include bisexual and transgender people in recognition of increased diversity among the population.
Well-structured, with topics that follow logically and many practical, treatment-oriented features, such as quick reference tables and lists of recommended readings, The American Psychiatric Publishing Textbook of Substance Abuse Treatment is a classic that will enhance the education and practice of clinicians.
Part I: The Basis of Addictive Disorders
Chapter 1. Neurobiology of Addiction
Chapter 2. Genetics of Addiction
Chapter 3. Epidemiology of Addiction
Chapter 4. Cross-Cultural Aspects of Addiction
Part II: The Nature of Treatment
Chapter 5. Science in the Treatment of Substance Abuse
Chapter 6. Assessment of the Patient
Chapter 7. Screening and Brief Intervention
Chapter 8. Patient Placement Criteria
Chapter 9. “Recovery” in Chronic Care Disease Management: “Disease Control” in Substance Use Disorders
Part III: Specific Drugs of Abuse
Chapter 10. Neurobiology of Alcohol Use Disorder
Chapter 11. Treatment of Alcohol Intoxication and Alcohol Withdrawal
Chapter 12. Neurobiology of Stimulants
Chapter 13. Clinical Management: Cocaine
Chapter 14. Clinical Management: Methamphetamine
Chapter 15. Hallucinogens and Club Drugs
Chapter 16. Tobacco Use Disorder
Chapter 17. Benzodiazepines and Other Sedatives and Hypnotics
Chapter 18. Treatment of Anabolic-Androgenic Steroid–Related Disorders
Chapter 19. Neurobiology of Opiates and Opioids
Chapter 20. Opioid Detoxification
Chapter 21. Methadone and Buprenorphine Maintenance
Chapter 22. Opioid Antagonists
Chapter 23. Neurobiology of Marijuana
Chapter 24. Treatment of Cannabis Use Disorder
Part IV: Treatment Modalities
Chapter 25. Psychodynamic Psychotherapy
Chapter 26. Cognitive-Behavioral Therapies
Chapter 27. Motivational Enhancement
Chapter 28. Twelve-Step Facilitation: An Adaptation for Psychiatric Practitioners and Patients
Chapter 29. Contingency Management
Chapter 30. Network Therapy
Chapter 31. Group Therapy
Chapter 32. Family Therapy
Part V: Rehabilitation Settings
Chapter 33. Inpatient Treatment
Chapter 34. Therapeutic Communities
Chapter 35. Community-Based Treatment
Chapter 36. History of Alcoholics Anonymous and the Experiences of Patients
Chapter 37. Psychological Mechanisms in Alcoholics Anonymous
Chapter 38. Outcomes Research on Twelve-Step Programs
Part VI: Special Populations
Chapter 39. Women and Addiction
Chapter 40. Perinatal Substance Use Disorders
Chapter 41. Adolescent Substance Use Disorders: Epidemiology, Neurobiology, and Screening
Chapter 42. Adolescent Substance Use Disorders: Transition to Substance Abuse, Prevention, and Treatment
Chapter 43. Psychiatric Consultation in Pain and Addiction
Chapter 44. Prevention of Prescription Drug Abuse
Chapter 45. HIV/AIDS and Hepatitis C
Chapter 46. Substance Use Disorders Among Physicians
Chapter 47. Substance Use Issues Among Gay, Lesbian, Bisexual, and Transgender People
Chapter 48. Minorities
Part VII: Special Topics
Chapter 49. Testing to Identify Recent Drug Use
Chapter 50. Medical Education on Addiction
Chapter 51. Prevention of Substance Abuse
Chapter 52. Forensic Addiction Psychiatry
Chapter 53. Substance Abuse and Mental Illness
Appendix: DSM-5 Substance-Related and Addictive Disorders
- Steven L. Batki, M.D.
Gillinder Bedi, D.Psych.
Adam Bisaga, M.D.
J. Wesley Boyd, M.D., Ph.D.
Kathleen T. Brady, M.D., Ph.D.
David W. Brook, M.D.
Oscar G. Bukstein, M.D., M.P.H.
Eduardo R. Butelman, Ph.D.
Robert Paul Cabaj, M.D.
Kathleen M. Carroll, Ph.D.
Albert E. Kent
Margaret S. Chisolm, M.D.
Richard R. Clayton, Ph.D.
Wilson M. Compton, M.D., M.P.E.
Gerard J. Connors, Ph.D.
Ziva D. Cooper, Ph.D.
Taylor Berens Crouch, M.A.
George De Leon, Ph.D.
Richard Denisco, M.D., M.P.H.
Carlo C. DiClemente, Ph.D., A.B.P.P.
Jessica A. Dreifuss, Ph.D.
Robert L. DuPont, M.D.
Nady el-Guebaly, M.D., D.Psych., D.P.H.
Patrick D. Fehling, M.D.
Richard J. Frances, M.D.
Marc Galanter, M.D.
David R. Gastfriend, M.D.
Joel Gelernter, M.D.
Douglas L. Gourlay, M.D., M.Sc., F.R.C.P.C., F.A.S.A.M.
Kevin M. Gray, M.D.
Preston Greene, Ph.D.
Shelly F. Greenfield, M.D., M.P.H.
Roland R. Griffiths, Ph.D.
Erik W. Gunderson, M.D., F.A.S.A.M.
Margaret Haney, Ph.D.
Rashelle Hayes, Ph.D.
Markus Heilig, M.D., Ph.D.
Howard A. Heit, M.D., F.A.C.P., F.A.S.A.M.
Grace Hennessy, M.D.
Jolomi Ikomi, M.D.
Matthew W. Johnson, Ph.D.
Hendree E. Jones, Ph.D.
David Kalman, Ph.D.
Karol Kaltenbach, Ph.D.
Yifrah Kaminer, M.D., M.B.A.
Gen Kanayama, M.D., Ph.D.
John F. Kelly, Ph.D.
Meredith A. Kelly, M.D.
Herbert D. Kleber, M.D.
John R. Knight, M.D.
George F. Koob, Ph.D.
Thomas R. Kosten, M.D.
Henry R. Kranzler, M.D.
Mary Jeanne Kreek, M.D.
Frances R. Levin, M.D.
Petros Levounis, M.D., M.A.
Hallie A. Lightdale, M.D.
Walter Ling, M.D.
Avram H. Mack, M.D.
Katherine A. MacLean, Ph.D.
John J. Mariani, M.D.
Laura F. Martin, M.D.
A. Thomas McLellan, Ph.D.
David Mee-Lee, M.D.
Louise Mewton, Ph.D.
Larissa J. Mooney, M.D.
Megan Moran-Santa Maria, Ph.D.
Hugh Myrick, M.D.
Edgar P. Nace, M.D.
Kalpana I. Nathan, M.D.
Angela A. Petersen, M.A.
Nancy Petry, Ph.D.
Roberto Picetti, Ph.D.
Daniele Piomelli, Ph.D.
Harrison G. Pope Jr., M.D.
Richard A. Rawson, Ph.D.
Brian Reed, Ph.D.
Richard K. Ries, M.D.
Jonathan I. Ritvo, M.D.
Stephen Ross, M.D.
Amanda T. Roten, M.D.
Richard Saitz, M.D., M.P.H.
Richard S. Schottenfeld, M.D.
Carl M. Selavka, Ph.D., D-ABC
Mehmet Sofuoglu, M.D., Ph.D.
Rainer Spanagel, Ph.D.
M. Duncan Stanton, Ph.D.
Maxine Stitzer, Ph.D.
Kenneth B. Stoller, M.D.
Eric C. Strain, M.D.
Maree Teesson, Ph.D.
Mishka Terplan, M.D., M.P.H.
Shayla T. Thrash, M.A.
J. Scott Tonigan, Ph.D.
Barney R. Vaughan, M.D.
Roger D. Weiss, M.D.
Joseph Westermeyer, M.D., M.P.H., Ph.D.
Julie D. Yeterian, M.A.
Douglas Ziedonis, M.D., M.P.H.
About the Authors
Marc Galanter, M.D., is Professor of Psychiatry and Director of the Division of Alcoholism and Drug Abuse at NYU School of Medicine in New York, New York.
Herbert D. Kleber, M.D., is Professor of Psychiatry and Director of the Division on Substance Abuse at Columbia University in New York, New York.
Kathleen T. Brady, M.D., Ph.D., is Distinguished University Professor, Associate Provost of Clinical and Translational Research, and Director of the South Carolina Clinical and Translational Research Institute in Charleston, South Carolina.
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, Fifth Edition, is an outstanding compendium of the latest information on the etiology and treatment of substance abuse and other addictive disorders. With chapter authors representing internationally recognized scientists and clinicians, the book covers an extraordinary breadth of topics from the latest advances in the neurobiology of addiction, to genetics, culture and the most sophisticated and comprehensive psychotherapeutic and psychopharmacological treatments currently available. This volume should be required reading for all practitioners in order to provide state of the art treatment for patients suffering from these conditions.—Carol A. Bernstein, M.D., Associate Professor of Psychiatry, Vice Chair for Education and Director of Residency Training, New York University School of Medicine, Past President, American Psychiatric Association
The 5th Edition of The American Psychiatric Publishing Textbook of Substance Abuse Treatment, edited by Marc Galanter, M.D., Herbert D. Kleber, M.D. and Kathleen T. Brady, M.D., Ph.D. has provided an outstanding textbook for those interested or dedicated to the field of addiction in the United States and abroad.—Pedro Ruiz, M.D., Professor & Executive Vice Chair, Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine President, World Psychiatry Association
The authors provide clearly structured examples of the essential elements of the assessment
process. Importantly, this text is fully updated to reflect the changes in the fifth edition of the
Diagnostic and Statistical Manual of Mental Disorders (DSM-5). A comprehensive review of placement criteria highlights the important standard that no single method or level of care is appropriate for all individuals. Readers are shown how to develop an appropriate assessment process that applies to multiple treatment settings while also respecting the culture and individuality of each person presenting to treatment.—John J. O'Neill, EdD, LCSW, LCDC, CAS, Vice President and Clinical Director, The Phoenix House, Austin, TX , Journal of Psychiatric Practice Vol. 23, No. 1, 01/01/2017
This is an authoritative reference that covers a wide range of clinical topics in addiction medicine. Each section is comprehensive and includes extensive references for more detailed information.—Michael Easton, M.D., Doody's Book Review